BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1345536)

  • 1. Growth rate in children with vitamin-D-dependent rickets in relation to 1-alpha-hydroxyvitamin D3 dosage.
    Pronicka E; Rowińska E; Buczeń K; Lorenc R; Gradzka I
    Endokrynol Pol; 1992; 43(2):145-52. PubMed ID: 1345536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,25-dihydroxyvitamin D3 and 1, alpha-hydroxyvitamin D3 in children: biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance.
    Balsan S; Garabedian M; Sorgniard R; Holick MF; Deluca HF
    Pediatr Res; 1975 Jul; 9(7):586-93. PubMed ID: 169507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linear growth in relation to the circulating concentrations of insulin-like growth factor I, parathyroid hormone, and 25-hydroxy vitamin D in children with nutritional rickets before and after treatment: endocrine adaptation to vitamin D deficiency.
    Soliman AT; Al Khalaf F; Alhemaidi N; Al Ali M; Al Zyoud M; Yakoot K
    Metabolism; 2008 Jan; 57(1):95-102. PubMed ID: 18078865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D and vitamin D dependency.
    Tsuchiya Y; Matsuo N; Cho H; Tsubouchi K; Kumagai M; Nishii Y; Nanjoh M; Yamamoto T
    Contrib Nephrol; 1980; 22():89-100. PubMed ID: 6967387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1 alpha-hydroxyvitamin D3 treatment of three patients with 1,25-dihydroxyvitamin D-receptor-defect rickets and alopecia.
    Takeda E; Kuroda Y; Saijo T; Naito E; Kobashi H; Yokota I; Miyao M
    Pediatrics; 1987 Jul; 80(1):97-101. PubMed ID: 3037475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to crystalline 1alpha-hydroxyvitamin D3 in vitamin D dependency.
    Reade TM; Scriver CR; Glorieux FH; Nogrady B; Delvin E; Poirier R; Holick F; DeLuca HF
    Pediatr Res; 1975 Jul; 9(7):593-9. PubMed ID: 1161348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single case of hypophosphatemic rickets with hypercalciuria.
    Nishiyama S; Inoue F; Matsuda I
    J Pediatr Gastroenterol Nutr; 1986; 5(5):826-9. PubMed ID: 3761117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic and collateral effects of 25-hydroxycholecalciferol in vitamin D deficiency.
    Moya M; Beltran J; Colomer J
    Eur J Pediatr; 1977 Dec; 127(1):49-55. PubMed ID: 23950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum 25-hydroxy-vitamin D levels in malnourished children with rickets.
    Raghuramulu N; Reddy V
    Arch Dis Child; 1980 Apr; 55(4):285-7. PubMed ID: 6774669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal hypophosphatemic rickets: growth acceleration after long-term treatment with 1,25-dihydroxyvitamin-D3.
    Chan JC; Lovinger RD; Mamunes P
    Pediatrics; 1980 Sep; 66(3):445-54. PubMed ID: 6893489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment of familial hypophosphatemic rickets with oral phosphate and 1 alpha-hydroxyvitamin D3.
    Rasmussen H; Pechet M; Anast C; Mazur A; Gertner J; Broadus AE
    J Pediatr; 1981 Jul; 99(1):16-25. PubMed ID: 6265614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 25-Hydroxycholecalciferol. A comparative study in deficiency rickets and different types of resistant rickets.
    Balsan S; Garabedian M
    J Clin Invest; 1972 Apr; 51(4):749-59. PubMed ID: 4335443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hypophosphataemic vitamin D-resistant rickets with massive doses of 1 alpha-hydroxy-vitamin D3 during childhood.
    Seino Y; Shimotsuji T; Ishii T; Ishida M; Ikehara C; Yamaoka K; Yabuuchi H; Dokoh S
    Arch Dis Child; 1980 Jan; 55(1):49-53. PubMed ID: 6246841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of long-term treatment with massive doses of 1 alpha-hydroxyvitamin D3 on calcium-phosphate balance in patients with vitamin D-dependent rickets type II.
    Takeda E; Yokota I; Saijo T; Kawakami I; Ito M; Kuroda Y
    Acta Paediatr Jpn; 1990 Feb; 32(1):39-43. PubMed ID: 2158205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of the stereochemical position of the 24-hydroxyl to biological activity of 24-hydroxyvitamin D3.
    Tanaka Y; Frank H; DeLuca HF; Koizumi N; Ikekawa N
    Biochemistry; 1975 Jul; 14(15):3293-6. PubMed ID: 1148204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1alpha-hydroxyvitamin D3 in the treatment of nutritional and metabolic rickets and osteomalacia.
    Gertner JM; Brenton DB; Edwards RH
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():239s-244s. PubMed ID: 203419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vitamin D-resistant rickets type II: apropos of 2 cases].
    Simonin G; Chabrol B; Moulene E; Bollini G; Strouc S; Mattei JF; Giraud F
    Pediatrie; 1992; 47(12):817-20. PubMed ID: 1338926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term therapy with 1alpha-hydroxyvitamin D3 in children with 'pseudo-deficiency' rickets.
    Balsan S; Garabedian M; Courtecuisse V; Guéris J; Dommergues JP; Creignou L; le Denuff MJ; Rivron J
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():225s-230s. PubMed ID: 203417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of nutritional rickets in Indian children: a randomized controlled trial.
    Aggarwal V; Seth A; Marwaha RK; Sharma B; Sonkar P; Singh S; Aneja S
    J Trop Pediatr; 2013 Apr; 59(2):127-33. PubMed ID: 23104564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative antirachitic activity of 1,25-dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 in the chick].
    Babarykin DA; Rozental' RL; Valinietse MIu; Bauman VK
    Vopr Med Khim; 1982; 28(2):64-6. PubMed ID: 6896250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.